Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Colonic cancer. Adjuvant therapy: the Italian experience].
Cascinu S, Salvagni S, Camisa R, Gasparro D, Biscari L, Pucci F, Leonardi F, Franciosi V. Cascinu S, et al. Among authors: leonardi f. Tumori. 2001 Jan-Feb;87(1 Suppl 1):S83-4. Tumori. 2001. PMID: 11300038 Italian. No abstract available.
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Cocconi G, Di Blasio B, Boni C, Bisagni G, Ceci G, Rondini E, Bella M, Leonardi F, Savoldi L, Camisa R, Bruzzi P. Cocconi G, et al. Among authors: leonardi f. Cancer. 2002 Jul 15;95(2):228-35. doi: 10.1002/cncr.10678. Cancer. 2002. PMID: 12124820 Free article. Clinical Trial.
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes.
Cocconi G, Di Blasio B, Boni C, Bisagni G, Rondini E, Bella MA, Leonardi F, Savoldi L, Vallisneri C, Camisa R, Bruzzi P; Italian Oncology Group for Clinical Research (GOIRC), Parma, Italy. Cocconi G, et al. Among authors: leonardi f. Ann Oncol. 2005 Sep;16(9):1469-76. doi: 10.1093/annonc/mdi278. Epub 2005 Jun 14. Ann Oncol. 2005. PMID: 15956038 Free article. Clinical Trial.
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity.
Bozzetti C, Musolino A, Camisa R, Bisagni G, Flora M, Bassano C, Martella E, Lagrasta C, Nizzoli R, Personeni N, Leonardi F, Cocconi G, Ardizzoni A. Bozzetti C, et al. Among authors: leonardi f. Am J Clin Oncol. 2006 Apr;29(2):171-7. doi: 10.1097/01.coc.0000204405.96572.f9. Am J Clin Oncol. 2006. PMID: 16601438
Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites.
Bozzetti C, Tiseo M, Lagrasta C, Nizzoli R, Guazzi A, Leonardi F, Gasparro D, Spiritelli E, Rusca M, Carbognani P, Majori M, Franciosi V, Rindi G, Ardizzoni A. Bozzetti C, et al. Among authors: leonardi f. J Thorac Oncol. 2008 Jan;3(1):18-22. doi: 10.1097/JTO.0b013e31815e8ba2. J Thorac Oncol. 2008. PMID: 18166836 Free article.
222 results